Product
Sm-p80
2 clinical trials
2 indications
Indication
SchistosomiasisIndication
schistosomiasisClinical trial
A Phase 1, Open-Label, Dose-Escalation Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy AdultsStatus: Completed, Estimated PCD: 2024-03-19
Clinical trial
A Phase 1, Open-Label, Dose-Escalation Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy AdultsStatus: Completed, Estimated PCD: 2024-03-19